Market Overview

Endoscope + Radiofrequency Ablation - Global Market Analysis & Forecast to 2025 by Application -


The "Endoscope
- Radiofrequency Ablation Market by Application - Global Opportunity
Analysis and Industry Forecast, 2017-2025"
report has been
added to's offering.

The global endoscope + radiofrequency ablation (RFA) market was valued
at $3,567.4 million in 2017 and is estimated to reach at $7,471.5
million by 2025, registering a CAGR of 9.6% from 2018 to 2025.

Upsurge in geriatric population that is highly susceptible to pain and
chronic disorders has a positive impact on the market growth. In
addition, rise in need for the development of advanced minimally
invasive surgical techniques has propelled the demand for endoscopic RFA
across healthcare settings, thus fueling the market growth.

However, dearth of skilled professionals that lack complete know-how of
endoscopic RFA treatment impedes the market growth. Conversely, high
untapped potential in the emerging economies is anticipated to offer
significant profitable opportunities for the expansion of the market.

The endoscope + radiofrequency ablation (RFA) market is segmented based
on application. On the basis of application, the market is categorized
into cardiology applications, pain management, oncology applications,
and others.

Market Dynamics


  • Increase in the Prevalence of Cancer and Cardiac Ailments Across the
  • Large Scale Adoption of Endoscopic RFA Devices in Pain Management
  • High Efficacy & Short Duration of the Procedure


  • High Costs Associated With the RFA Treatment
  • Limited Awareness Regarding Available RFA + Endoscope Devices


  • Emerging Indications for the Endoscopic Radiofrequency Ablation

Key Players Profiled

  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic PLC
  • Smith & Nephew PLC
  • Stryker Corporation

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Endoscope + Radiofrequency Ablation (RFA) Market, by

Chapter 5: Company Profiles

  • Boston Scientific Corporation
  • Conmed Corporation
  • Medtronic PLC
  • Smith & Nephew PLC
  • Stryker Corporation

For more information about this report visit

View Comments and Join the Discussion!